Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Mar 2018 16:14

RNS Number : 1344J
Premier Veterinary Group PLC
27 March 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Premier Veterinary Group Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Killik & Co LLP

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

Platform Securities

(on behalf of various discretionary clients of Killik & Co LLP)

City and country of registered office (if applicable)

London, UK

5. Date on which the threshold was crossed or reachedvi:

21st March 2018

6. Date on which issuer notified (DD/MM/YYYY):

22nd March 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.67%

15,346,950

Position of previous notification (if

applicable)

4.71%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GBP Ord

GB00BSZLMS59

562,573

3.67%

SUBTOTAL 8. A

562,573

3.67%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Compliance Dept. Killik & Co LLP, Crown House, Crown Street, Ipswich, Suffolk, IP1 3HS

Date of completion

22nd March 2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASDXAFAPEFF
Date   Source Headline
17th May 201010:17 amRNSForm 8.5 (EPT/NON-RI)
14th May 201011:16 amRNSForm 8.5 (EPT/RI)
14th May 20109:36 amRNSForm 8.5 (EPT/NON-RI)
12th May 201010:39 amRNSForm 8.5 (EPT/RI)
12th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
11th May 20108:41 amRNSForm 8.5 (EPT/NON-RI)
10th May 20104:19 pmRNSForm 8.3 - [Ark Therapeutics Grp]
10th May 201010:41 amRNSForm 8.5 (EPT/NON-RI)
7th May 20102:37 pmRNSForm 8.3 - Ark Therapeutics Grp
7th May 201010:03 amRNSForm 8.5 (EPT/RI)
7th May 201010:01 amRNSForm 8.5 (EPT/NON-RI)
6th May 201012:24 pmRNSForm 8.3 - Ark Therapeutics Group PLC
6th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
5th May 201011:48 amRNSForm 8.3 - (Ark Therapeutics)
5th May 20107:00 amRNSStrategic Review
4th May 20101:54 pmRNSForm 8 (OPD) Ark Therapeutics Group
4th May 20101:36 pmRNSForm 8.5 (EPT/NON-RI)
30th Apr 20101:43 pmRNSForm 8.3 - Ark Therapeutics Group PLC
30th Apr 201012:05 pmRNSTotal Voting Rights
30th Apr 201012:03 pmRNSDirector/PDMR Shareholding
30th Apr 201011:55 amRNSForm 8 (DD) - Ark Therapeutics Group PLC
30th Apr 201010:49 amRNSForm 8.5 (EPT/RI)
29th Apr 201011:11 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 201011:04 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
28th Apr 201010:31 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201011:40 amRNSForm 8.5 (EPT/RI)
26th Apr 20102:53 pmRNSForm 8.3 - ARK THERAPEUTICS
26th Apr 201012:43 pmRNSForm 8.3 - Ark Therapeutics Group plc
26th Apr 201011:30 amRNSForm 8.5 (EPT/RI)
26th Apr 20109:42 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 201011:43 amRNSForm 8.3 - ARK THERAPEUTICS
23rd Apr 201011:36 amRNSForm 8.5 (EPT/RI)
23rd Apr 201010:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 201011:33 amRNSForm 8.3 - ARK THERAPEUTICS
22nd Apr 201011:03 amRNSForm 8.3 - Ark Therapeutics Group Plc
22nd Apr 20109:48 amRNSForm 8.5 (EPT/RI)
21st Apr 20101:47 pmRNSForm 8.3 - ARK THERAPEUTICS
21st Apr 201012:05 pmRNSResult of AGM
21st Apr 20109:11 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20103:56 pmRNSForm 8.3 - Ark Therapeutics Group Plc
20th Apr 201012:49 pmBUSForm 8.3 - Ark Therapeutics Group plc
20th Apr 201011:37 amRNSForm 8.5 (EPT/RI)
20th Apr 20109:48 amRNSForm 8.3 - Ark Therapeutics Plc
20th Apr 20108:53 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
19th Apr 201011:31 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20107:00 amRNSResearch Update
16th Apr 201010:32 amRNSEPT Disclosure
16th Apr 20109:32 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.